| Name | Title | Contact Details |
|---|
Community Health Center Network is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Leandro, CA. To find more information about Community Health Center Network, please visit www.chcnetwork.org
A premier provider of high quality, behavioral health care founded in 1999 and headquartered in central Pennsylvania, we operate over 80 facilities across the Commonwealth, New Jersey, and North Carolina and offer a full continuum of mental health, treatment and recovery services for adults and teens. Our dedicated admissions representatives are available to schedule confidential assessments and admissions, recommend appropriate treatment options, assist with insurance verification and facilitate complimentary transportation to and from our detox and inpatient program locations.
It`s good to be home! Jet Health is a provider of skilled home health, hospice, personal care, and companion services. Founded in April 2016, Jet Health is building a national platform through organic growth, strategic acquisitions, and de novo build-outs in target markets. These markets are typically mid-sized cities that have under served and growing Medicare populations. Jet Health leverages local brands and operating expertise while sharing best practices across its companies and centralizes traditional back office functions. The company believes that its four cornerstones: superior service, clinical excellence, compliant business practices and an employee centric environment, provide a solid foundation upon which to build a successful company in the home health marketplace.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.
TriHealth is the healthcare system that formed as a partnership between Good Samaritan Hospital and Bethesda Hospital, Inc. Through acute care hospitals and more than 80 locations, TriHealth provides a wide range of clinical, educational, preventive an...